These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6595483)

  • 1. Enhanced tumor load reduction after chemotherapy induced recruitment and synchronization in a slowly growing rat leukemia model (BNML) for human acute myelocytic leukemia.
    Colly LP; van Bekkum DW; Hagenbeek A
    Leuk Res; 1984; 8(6):953-63. PubMed ID: 6595483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the interval between high dose 1-beta-D-arabinofuranosylcytosine injections on leukemic cell load, intestinal toxicity, and normal hematopoietic stem cells in a rat model for acute myelogenous leukemia.
    Colly LP; Peters WG; Willemze R
    Cancer Res; 1986 Aug; 46(8):3825-7. PubMed ID: 3460691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell kinetic studies after high dose Ara-C and adriamycin treatment in a slowly growing rat leukemia model (BNML) for human acute myelocytic leukemia.
    Colly LP; van Bekkum DW; Hagenbeek A
    Leuk Res; 1984; 8(6):945-52. PubMed ID: 6595482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo studies on high-dose 1-beta-D-arabinofuranosylcytosine (HDara-C) and 1-beta-D-arabinofuranosyluracil (ara-U) with respect to pharmacokinetics, cell kinetics, and cytotoxicity in a rat myelocytic leukemia model (BNML).
    Colly LP; Willemze R; Honders W; vd Hoorn F; Edelbroek PM
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):49-54. PubMed ID: 3859932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity of doxorubicin for normal hematopoietic and acute myeloid leukemia cells of the rat.
    Sonneveld P; Mulder Ja; van Bekkum DW
    Cancer Chemother Pharmacol; 1981; 5(3):167-73. PubMed ID: 6945921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the antileukaemic activity of 5 aza-2-deoxycytidine and arabinofuranosyl-cytosine in rats with myelocytic leukaemia.
    Richel DJ; Colly LP; Lurvink E; Willemze R
    Br J Cancer; 1988 Dec; 58(6):730-3. PubMed ID: 2465015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a cell kinetic approach to curative therapy of acute myelocytic leukemia in remission using the cell cycle-specific drug 1-beta-D-arabinofuranosylcytosine in a rat model.
    Vaughan WP; Burke PJ
    Cancer Res; 1983 May; 43(5):2005-9. PubMed ID: 6572561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryopreservation of autologous marrow grafts in acute leukemia: survival of in vivo clonogenic leukemic cells and normal hemopoietic stem cells.
    Hagenbeek A; Martens AC
    Leukemia; 1989 Jul; 3(7):535-7. PubMed ID: 2659904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of dose and duration of exposure on the cytotoxic effect of cytarabine toward human hematopoietic clonogenic cells.
    Muus P; Haanen C; Raijmakers R; de Witte T; Salden M; Wessels J
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):238-44. PubMed ID: 3473679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schedule-dependent interaction of cytarabine plus doxorubicin or cytarabine plus mitoxantrone in acute myelocytic leukemia cells in culture.
    Fountzilas G; Inoue S; Ohnuma T
    Leukemia; 1990 May; 4(5):321-4. PubMed ID: 2388478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate-specific deoxycytidine kinase deficiency in 1-beta-D-arabinofuranosylcytosine-resistant leukemic cells.
    Richel DJ; Colly LP; Arkesteijn GJ; Arentsen-Honders MW; Kerster MG; ter Riet PM; Willemze R
    Cancer Res; 1990 Oct; 50(20):6515-9. PubMed ID: 2208110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chemotherapy on bone marrow stroma in mice with acute myelogenous leukemia. Correlation with CFU-C and CFU-D.
    Ben-Ishay Z; Prindull G; Sharon S; Borenstein A
    Leuk Res; 1985; 9(8):1059-67. PubMed ID: 3862923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic cytotoxicity of cytosine arabinoside and mitoxantrone for K562 and CFU-GM.
    Krehmeier C; Zühlsdorf M; Büchner T; Hiddemann W
    Haematol Blood Transfus; 1990; 33():129-32. PubMed ID: 2323625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dexamethasone on the antileukemic effect of cytarabine: role of deoxycytidine kinase.
    Jaramillo AC; Bergman AM; Comijn EM; Jansen G; Kaspers GJL; Cloos J; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(10-12):1346. PubMed ID: 32727269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity of ASTA Z 7557 (INN mafosfamide) to normal- and leukemic stem cells: implications for autologous bone marrow transplantation.
    Hagenbeek A; Martens AC
    Invest New Drugs; 1984; 2(2):237-43. PubMed ID: 6381383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro sensitivity of CFU-L to cytosine arabinoside (Ara-C).
    Marie JP; Zittoun R
    Med Pediatr Oncol; 1982; 10 Suppl 1():263-7. PubMed ID: 6962323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetyldinaline: a new oral cytostatic drug with impressive differential activity against leukemic cells and normal stem cells--preclinical studies in a relevant rat model for human acute myelocytic leukemia.
    el-Beltagi HM; Martens AC; Lelieveld P; Haroun EA; Hagenbeek A
    Cancer Res; 1993 Jul; 53(13):3008-14. PubMed ID: 8319208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of acute myelocytic leukemia with interleukin-6 Pseudomonas exotoxin fusion protein in a rat leukemia model.
    Rozemuller H; Rombouts WJ; Touw IP; FitzGerald DJ; Kreitman RJ; Pastan I; Hagenbeek A; Martens AC
    Leukemia; 1996 Nov; 10(11):1796-803. PubMed ID: 8892684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation.
    te Boekhorst PA; Löwenberg B; Vlastuin M; Sonneveld P
    Leukemia; 1993 Aug; 7(8):1191-8. PubMed ID: 7688839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of mast cell growth factor on Ara-C mediated acute myeloid leukemia cell killing.
    Tafuri A; De Felice L; Mascolo MG; Valentini T; Petrucci MT; Petti MC
    Stem Cells; 1993 Jul; 11 Suppl 2():88-92. PubMed ID: 7691332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.